ALX Oncology Holdings Stock (NASDAQ: ALXO) stock price, news, charts, stock research, profile.
You can purchase shares of ALX Oncology Holdings (NASDAQ:ALXO) through any online brokerage.
Other companies in ALX Oncology Holdings’s space includes: Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE) and Inozyme Pharma (NASDAQ:INZY).
ALX Oncology Holdings has a consensus price target of $15.29.
The stock price for ALX Oncology Holdings (NASDAQ: ALXO) is $1.635 last updated January 16, 2025 at 2:23 PM EST.
There are no upcoming dividends for ALX Oncology Holdings.
ALX Oncology Holdings’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for ALX Oncology Holdings.
ALX Oncology Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.